Rees Scientific continues to be impressed with the work put in by our clients. NIH, a Rees Scientific customer, recently announced the COVID-19 vaccine candidate developed with Moderna has advanced to a Phase 3 clinical trial, after showing promising results in Phase 1 and 2.
Rees Scientific provides continuous automated monitoring to a limitless number of applications in a wide range of industries. From Pharmaceutical to Blood Banking, Laboratory Animal Research to Biotech and Hospitals, Rees has become the standard by which other monitoring systems are judged.
This post is related to:
